» Articles » PMID: 29162266

Plasma Free Carnitine in Severe Trauma: Influence of the Association with Traumatic Brain Injury

Overview
Journal Injury
Publisher Elsevier
Specialty Emergency Medicine
Date 2017 Nov 23
PMID 29162266
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic response to severe trauma requires early nutritional resuscitation. Carnitine is essential for lipolysis, the energy source during this hypercatabolic phase. However l-carnitine is not present in nutritional replacement solutions. Furthermore, free carnitine depletion, defined as carnitine plasma level under 36μmol/L, was not adequately reported in adult patients with severe trauma. The aim of this study was to assess plasma free carnitine levels and factors of variation in severe trauma.

Method: Our observational study concerned 38 trauma patients including 18 with traumatic brain injury (TBI). On the third day after trauma, plasma free carnitine concentration was determined (by enzymatic method) while patients received artificial nutrition.

Results: Low plasmatic free carnitine concentration was evidenced in 95% of the patients with a median value of 18μmol/L (11-47). Univariate analysis showed that mean arterial pressure, serum urea, CKD-EPI and patients with TBI were significantly associated with plasma free carnitine concentration less than 18μmol/L. Lower plasma free carnitine concentration was observed in the group of patients with TBI with 17.72μmol/L (11-36) versus 21.5μmol/L (11-47) for others patients (p=0.031). Logistic regression analysis showed that severe trauma with TBI and CKD-EPI above 94mL/min/1.73m2 appeared to be independent predictor of lower free carnitine plasmatic concentration (Goodness of fit=0.87 and AUC=0.89).

Conclusion: Our observations support hypotheses that plasma free carnitine concentration is lowered in severe injured patients especially for TBI patients and patients with estimated GFR above 94mL/min/1.73m.

Citing Articles

Effect of parenteral L-carnitine in hospitalized patients with moderate to severe COVID-19: A randomized double-blind clinical trial.

Naeimzadeh F, Sadeghi A, Saghaleini S, Sarbakhsh P, Mahmoodpoor A, Gharekhani A Bioimpacts. 2025; 15:30261.

PMID: 39963575 PMC: 11830133. DOI: 10.34172/bi.2024.30261.


Metabolic-driven analytics of traumatic brain injury and neuroprotection by ethyl pyruvate.

Golovachev N, Siebold L, Sutton R, Ghavim S, Harris N, Bartnik-Olson B J Neuroinflammation. 2024; 21(1):294.

PMID: 39538295 PMC: 11562096. DOI: 10.1186/s12974-024-03280-8.


The Effect of L-Carnitine on Critical Illnesses Such as Traumatic Brain Injury (TBI), Acute Kidney Injury (AKI), and Hyperammonemia (HA).

Sharma B, Schmidt L, Nguyen C, Kiernan S, Dexter-Meldrum J, Kuschner Z Metabolites. 2024; 14(7).

PMID: 39057686 PMC: 11278892. DOI: 10.3390/metabo14070363.


Effects of Traumatic Brain Injury on the Gut Microbiota Composition and Serum Amino Acid Profile in Rats.

Taraskina A, Ignatyeva O, Lisovaya D, Ivanov M, Ivanova L, Golovicheva V Cells. 2022; 11(9).

PMID: 35563713 PMC: 9102408. DOI: 10.3390/cells11091409.


Exogenous L-carnitine ameliorates burn-induced cellular and mitochondrial injury of hepatocytes by restoring CPT1 activity.

Li P, Xia Z, Kong W, Wang Q, Zhao Z, Arnold A Nutr Metab (Lond). 2021; 18(1):65.

PMID: 34167568 PMC: 8223334. DOI: 10.1186/s12986-021-00592-x.